486 related articles for article (PubMed ID: 11764081)
41. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
42. The normal counterpart to the chronic lymphocytic leukemia B cell.
Caligaris-Cappio F; Ghia P
Best Pract Res Clin Haematol; 2007 Sep; 20(3):385-97. PubMed ID: 17707828
[TBL] [Abstract][Full Text] [Related]
43. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy.
Donisi PM; Di Lorenzo N; Riccardi M; Paparella A; Sarpellon C; Zupo S; Bertoldero G; Minotto C; Stracca-Pansa V
Diagn Mol Pathol; 2006 Dec; 15(4):206-15. PubMed ID: 17122648
[TBL] [Abstract][Full Text] [Related]
44. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.
Kroft SH; Dawson DB; McKenna RW
Am J Clin Pathol; 2001 Mar; 115(3):385-95. PubMed ID: 11242795
[TBL] [Abstract][Full Text] [Related]
45. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
46. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis.
Cuneo A; Rigolin GM; Bigoni R; De Angeli C; Veronese A; Cavazzini F; Bardi A; Roberti MG; Tammiso E; Agostini P; Ciccone M; Della Porta M; Tieghi A; Cavazzini L; Negrini M; Castoldi G
Leukemia; 2004 Mar; 18(3):476-83. PubMed ID: 14712287
[TBL] [Abstract][Full Text] [Related]
47. High resolution immunophenotypic analysis of chronic lymphocytic leukemic cells by enzymatic amplification staining.
Kaplan D; Meyerson H; Lewandowska K
Am J Clin Pathol; 2001 Sep; 116(3):429-36. PubMed ID: 11554172
[TBL] [Abstract][Full Text] [Related]
48. IgD can largely substitute for loss of IgM function in B cells.
Lutz C; Ledermann B; Kosco-Vilbois MH; Ochsenbein AF; Zinkernagel RM; Köhler G; Brombacher F
Nature; 1998 Jun; 393(6687):797-801. PubMed ID: 9655395
[TBL] [Abstract][Full Text] [Related]
49. Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.
Fais F; Sellars B; Ghiotto F; Yan XJ; Dono M; Allen SL; Budman D; Dittmar K; Kolitz J; Lichtman SM; Schulman P; Schuster M; Vinciguerra VP; Rai K; Stevenson FK; Gregersen PK; Ferrarini M; Chiorazzi N
J Clin Invest; 1996 Oct; 98(7):1659-66. PubMed ID: 8833916
[TBL] [Abstract][Full Text] [Related]
50. Isotype commitment of human B cells that are transformed by Epstein-Barr virus.
Miyawaki T; Butler JL; Radbruch A; Gartland GL; Cooper MD
Eur J Immunol; 1991 Jan; 21(1):215-20. PubMed ID: 1846818
[TBL] [Abstract][Full Text] [Related]
51. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
52. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
[TBL] [Abstract][Full Text] [Related]
53. Expression of IgD on B cell malignancy. An immunopathological study of 50 cases.
Mori S; Hagiwara S; Kodo H; Mohri N
Acta Pathol Jpn; 1986 Oct; 36(10):1429-40. PubMed ID: 3099539
[TBL] [Abstract][Full Text] [Related]
54. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
[TBL] [Abstract][Full Text] [Related]
55. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders.
McCarron KF; Hammel JP; Hsi ED
Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881
[TBL] [Abstract][Full Text] [Related]
56. IL-5 induces IgG1 isotype switch recombination in mouse CD38-activated sIgD-positive B lymphocytes.
Mizoguchi C; Uehara S; Akira S; Takatsu K
J Immunol; 1999 Mar; 162(5):2812-9. PubMed ID: 10072528
[TBL] [Abstract][Full Text] [Related]
57. Aberrant CD8 expression in B-chronic lymphocytic leukemia: report of five cases.
Parisi-Duchêne E; Mazurier I; Moskovtchenko P
Acta Haematol; 2006; 115(1-2):74-7. PubMed ID: 16424654
[TBL] [Abstract][Full Text] [Related]
58. MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Ito M; Iida S; Inagaki H; Tsuboi K; Komatsu H; Yamaguchi M; Nakamura N; Suzuki R; Seto M; Nakamura S; Morishima Y; Ueda R
Jpn J Cancer Res; 2002 Jun; 93(6):685-94. PubMed ID: 12079517
[TBL] [Abstract][Full Text] [Related]
59. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice.
Donís-Hernández FR; Parkhouse RM; Santos-Argumedo L
Eur J Immunol; 2001 Apr; 31(4):1261-7. PubMed ID: 11298353
[TBL] [Abstract][Full Text] [Related]
60. The clinical and biological features of a series of immunophenotypic variant of B-CLL.
Cro L; Ferrario A; Lionetti M; Bertoni F; Zucal N N; Nobili L; Fabris S; Todoerti K; Cortelezzi A; Guffanti A; Goldaniga M; Marcheselli L; Neri A; Lambertenghi-Deliliers G; Baldini L
Eur J Haematol; 2010 Aug; 85(2):120-9. PubMed ID: 20408870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
